Rapid growth in the medical device industry and changes in the regulatory environment have propelled valuations in the medtech sector to the high end of the range.

The average mid cap score is 53.83, below the four week moving average score of 57. The average mid cap is trading -14.64% below its 52 week high, 1.54% above its 200 dma, has 6.2 days to cover held short, and is expected to grow earnings by 19% next year.